Crystal structure of oxibendazole, C12H15N3O3

被引：0
|
作者：
Kaduk, James A. A. [1 ,2 ]
Gates-Rector, Stacy [3 ]
Blanton, Thomas N. N. [3 ]
机构：
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
来源：
POWDER DIFFRACTION | 2023年 / 38卷 / 01期
关键词：
oxibendazole; Loditac; powder diffraction; Rietveld refinement; density functional theory; POWDER; VALIDATION; PATTERNS; DENSITY;
D O I：
10.1017/S0885715622000495
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
The crystal structure of oxibendazole has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Oxibendazole crystallizes in space group C2/c (#15) with a = 23.18673(22), b = 5.35136(5), c = 19.88932(13) angstrom, beta = 97.0876(9)degrees, V = 2449.018(17) angstrom(3), and Z = 8. The structure consists of hydrogen-bonded layers of planar molecules parallel to the bc-plane. Strong N-HMIDLINE HORIZONTAL ELLIPSISN hydrogen bonds link the molecules into dimers, with a graph set R2,2(8). N-HMIDLINE HORIZONTAL ELLIPSISO hydrogen bonds further link these dimers into layers parallel to the bc-plane. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (TM) (PDF (R)).
引用
收藏
页码：15 / 20
页数：6
相关论文
共 50 条
  • [31] Crystal structure of ribociclib hydrogen succinate, (C23H31N8O)(HC4H4O4)
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, : 227 - 234
  • [32] Crystal structure of palbociclib isethionate Form B, (C24H30N7O2)(C2H5O4S)
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2021, 36 (03) : 196 - 201
  • [33] Crystal structure of vardenafil hydrochloride trihydrate, C23H33N6O4SCI (H2O)3
    Wheatley, Austin M.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2018, 33 (04) : 319 - 326
  • [34] Crystal structure of imepitoin, C13H14ClN3O2
    Kaduk, James A.
    Gindhart, Amy M.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 206 - 210
  • [35] Crystal structure of terazosin hydrochloride dihydrate (Hytrin®), C19H26N5O4Cl(H2O)2
    Wheatley, Austin M.
    Kaduk, James A.
    Vickers, Martin
    Gindhart, Amy M.
    Sunzeri, Joseph G.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2018, 33 (03) : 229 - 236
  • [36] Crystal structure of rivastigmine hydrogen tartrate Form I (Exelon®), C14H23N2O2(C4H5O6)
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2016, 31 (02) : 97 - 103
  • [37] Crystal structure of minocycline hydrochloride dihydrate form A, C23H28N3O7Cl (H2O)2
    Wheatley, Austin M.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (01) : 59 - 65
  • [38] Crystal structure of hydrocortisone acetate, C23H32O6
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2017, 32 (01) : 31 - 34
  • [39] Crystal structure of indacaterol hydrogen maleate (C24H29N2O3)(HC4H2O4)
    Kaduk, James A.
    Rost, Megan M.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (02) : 76 - 81
  • [40] Proposed crystal structure of carbadox, C11H10N4O4
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (02) : 82 - 93
12345